BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 17, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

fentanyl effervescent buccal tablet regulatory update

FDA approved an ANDA from Watson Pharmaceuticals Inc. (NYSE:WPI, Corona, Calif.) for a generic version of fentanyl buccal tablets. Watson is enjoined from launching the generic...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >